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The CRISPR system provides adaptive immunity against mobile genetic elements in 
prokaryotes, utilising small CRISPR RNAs which direct effector complexes to degrade 
invading nucleic acids 1-3. Type III effector complexes were recently demonstrated to 
synthesise a novel second messenger, cyclic oligoadenylate (cOA), on binding target 
RNA 4,5. cOA in turn binds to and activates ribonucleases and other factors via a CARF 
(CRISPR associated Rossman Fold) domain, inducing an antiviral state in the cell that 
is important for immunity. The mechanism of the “off-switch” that resets the system is 
not understood. Here, we report the identification of the nuclease that degrades these 
cOA ring molecules. The “Ring nuclease” is itself a CARF family protein with a metal 
independent mechanism, which cleaves cA4 rings to generate linear di-adenylate 
species and switches off the antiviral state. The identification of Ring nucleases adds 
an important insight to the CRISPR system.  
Cyclic oligoadenylate (cOA, with a ring size of 4 or 6 AMP monomers) has emerged as a key 
second messenger signalling the presence of invading mobile genetic elements in prokaryotes 
harbouring type III (Csm/Cmr) CRISPR systems 4,5. cOA is synthesised by the Cyclase domain 
of the Cas10 subunit, which is activated by the binding of target RNA. cOA in turn activates a 
range of proteins with CARF (CRISPR associated Rossman Fold) domains including HEPN 
(Higher Eukaryotes and Prokaryotes Nucleotide binding) domain ribonucleases (Csm6/Csx1) 
and transcription factors 6-8, precipitating an antiviral state in infected cells that may enhance 
viral clearance, result in dormancy, or cell death 9. There are interesting parallels with the 
cGAS-cGAMP-STING pathway in eukaryotes, where detection of DNA in the cytoplasm leads 
to synthesis of a cyclic nucleotide that activates the host immune response 10. The HEPN 
ribonucleases are important for CRISPR-based immunity 11-13. cOA is therefore a potent 
signalling molecule that must be tightly controlled if cells are to survive a viral infection. cOA 
synthesis is switched off when type III effectors cleave and release viral RNA targets 5,14. 
However, this will not remove extant cOA, potentially leading to untrammelled ribonuclease 
activity and cell death. Other cyclic nucleotide signalling molecules in prokaryotes, such as di-
cAMP, are degraded by specific phosphodiesterases 15,16, but the enzyme specific for cOA is 
unknown. Here, we report the identification and characterisation of a family of enzymes that 
degrade cA4, providing a mechanism for the deactivation of the antiviral state induced by cOA 
in cells harbouring a type III CRISPR system. 
To identify the enzyme responsible for the degradation of cOA, we undertook a classical 
biochemical approach. Starting with a cell lysate from the crenarchaeote Sulfolobus 
solfataricus (Sso), we noted the presence of an activity that converted radioactively labelled 
cA4 into a form (X) that migrated more slowly in denaturing gel electrophoresis (Fig. 1). We 
fractionated the cell lysate through three chromatography steps (phenyl-sepharose, size 
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exclusion and heparin) and followed the activity. The final purification step was followed by 
assay of each fraction and SDS-PAGE analysis (Fig. 1d), revealing that the activity correlated 
with a single protein that was identified by mass spectrometry as Sso2081 – a member of the 
CARF domain-containing protein family 17. To confirm that Sso2081 was the nuclease 
responsible for degradation of cA4, we expressed and purified the recombinant protein in E. 
coli. The enzyme converted cA4 to a slower-migrating species on gel electrophoresis, as seen 
for the activity from S. solfataricus, in a reaction independent of divalent metal ions (Fig. 1e). 
We noted that the Csx1 nuclease (Sso1389; PDB 2I71) 14 is found close to an uncharacterised 
CARF domain protein of known structure, Sso1393 that is homologous to Sso2081 (Extended 
Data Fig. 1 & 2). Pure recombinant Sso1393 also exhibits cA4 degradation activity, whilst Csx1 
does not (Fig. 1e). In contrast, of the three enzymes, only Csx1 displays cA4-stimulated 
ribonuclease activity on a linear RNA substrate (Fig. 1f). Sso2081 and Sso1393 degrade cA4 
with single-turnover rate constants of 0.23 ± 0.01 and 0.024 ± 0.0004 min-1, respectively (Fig. 
2a and Extended Data Fig. 3).  The ten-fold higher specific activity of Sso2081, combined with 
its higher expression levels in S. solfataricus 18, suggest that it is the major cA4-degrading 
enzyme in this organism.  
Metal independent ribonucleases and ribozymes, including the Cas6 nuclease family 19, share 
a common mechanism: activation of the 2’-hydroxyl of the ribose sugar as the nucleophile that 
attacks the phosphodiester bond targeted for cleavage, leading to products with a cyclic 2’,3’-
phosphate and a 5’-hydroxyl moiety 20. To determine the degradation products of cA4 treated 
with Sso2081 and 1393, we analysed radioactively labelled species by thin layer 
chromatography (TLC) (Fig. 2b and Extended Data Fig 4). Sso2081 converted cA4 into a 
faster-migrating form (X) that could be phosphorylated by treatment with polynucleotide kinase 
(PNK), showing that it was a linear product with a 5’-OH group (lanes 2 and 3). For Sso1393 
an intermediate product (Y) with a 5’-OH group that converted over time into the final product 
(X) was also observed (lanes 4-7). Lanes 8 and 9 show standards generated by cleavage of 
RNA oligonucleotides by the MazF ribonuclease 14 to generate the species P-A2>P (5’-
phospho-ApAp with a cyclic 2’,3’ phosphate) and P-A4>P, respectively. The final products of 
Sso2081 and 1393 run at the same position as the P-A2>P standard once phosphorylated by 
PNK, whilst the intermediate observed for Sso1393 runs at the same position as the P-A4>P 
standard. 
To identify products X and Y, we incubated Sso2081 and 1393 individually with cA4 and 
analysed the reaction products by liquid chromatography-high resolution mass spectrometry 
(LC-HRMS, Fig. 2c and d). Upon 60 min incubation with recombinant Sso2081, the peak 
corresponding to cA4 had almost completely disappeared in favour of the main product (X) 
with a retention time of 4.4 min alongside a trace of compound Y eluting at 11.9 min (Fig. 2c 
and Extended Data Fig. 5). Linear A2 and A4 species with a 2',3’-cyclic phosphate, generated 
using the MazF toxin 14, eluted with comparable retention times as products X and Y, 
respectively. Mass spectrometry revealed product X to have a neutral mass of 658.104 amu, 
consistent with linear A2>P. The mass of product Y (1316.208 amu), on the other hand, was 
consistent with A4>P. The same products were observed for Sso1393 (Fig. 2d and Extended 
Data Fig. 6). Again, A2>P (X) was the main product, with A4>P (Y) more visible at early time 
points, consistent with the slower catalytic rate of Sso1393. Thus, these enzymes break the 
cA4 ring using a metal-independent mechanism, generating linear A4>P intermediate and A2>P 
products with 5’-OH and 2’,3’-cyclic phosphate termini. We tested the specific activity of 
Sso2081 against available cyclic nucleotide molecules: cA6, cA4, cyclic di-AMP, cyclic di-GMP 
and cyclic GMP-AMP (Extended Data Fig. 7) confirming that the enzyme is highly specific for 
degradation of cA4, with a very low level of activity directed against cA6 and no detectable 
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degradation of the cyclic di-nucleotides. We propose the collective term “Ring nucleases” for 
this family of phosphodiesterases. 
The structure of Sso1393 (PDB 3QYF, unpublished) reveals a canonical CARF domain 
formed by a homodimeric subunit arrangement, with a C-terminal extension. To elucidate the 
mechanism of Ring nucleases, we docked cA4 into the CARF domain of Sso1393 (Fig. 3a and 
Extended Data Fig. 8). This simple model without energy minimisation allows hypotheses 
concerning the enzyme mechanism to be drawn. Using structure-guided multiple sequence 
alignment of Sso1393, Sso2081 and homologues (Extended Data Fig.2), we identified 
conserved residues positioned close to the cA4 binding site that might play a role in catalysis 
(Fig. 3). We noted the conservation of a lysine (K168 in Sso1393) predicted to lie in the centre 
of the cA4 binding site, which could play a role in catalysis. Sso2081 has two basic residues 
(R105/K106) in this position. The K168A variant of Sso1393 was catalytically inactive, as was 
the Sso2081 R105A/K106A variant, confirming an important role in catalysis, possibly by 
stabilising the pentacovalent phosphorous generated in the transition state 20 (Fig. 3b, 
Extended Data Fig.8). The conserved residue S11 is also implicated in catalysis. The S11A 
variant had a catalytic rate constant reduced by 3.5 and 32-fold for Sso2081 and Sso1393, 
respectively (Fig. 3b, Extended Data Fig.8). Consistent with the absence of Ring nuclease 
activity, Csx1 lacks these key active site residues.  
Based on the evidence available, we propose that cleavage of cA4 is catalysed by binding the 
molecule in an orientation that allows the 2’-hydroxyl of the ribose to attack the bridging 
phosphorus, coupled with stabilisation of the developing transition state by the basic 
residue(s) at the base of the binding pocket (Fig. 3c).  The single turnover rate constant for 
Sso2081, at below 1 min-1, is comparable to the Cas6 nuclease family, which use a similar 
mechanism 19,21. Given the dimeric organisation of the CARF domain, there is the possibility 
for two active sites acting on opposite sides of the cA4 ring, consistent with the observation of 
an A2>P product. For the slower Sso1393 enzyme, appreciable levels of A4>P intermediate 
were observed, suggesting that the two active sites need not function in a concerted manner. 
We next wished to reconstitute the cOA signalling system in vitro to confirm the function of the 
Ring nucleases. We first tested the ability of Ring nucleases to deactivate Csx1, observing 
that as cA4 is converted to A2>P, the activation of the Csx1 ribonuclease is abrogated 
(Extended Data Fig. 9). We next set up a reaction containing the Csm effector complex, 0.5 
mM ATP and a variable concentration of target RNA from 10 to 0.01 nM, to activate cA4 
synthesis.  After incubation for 1 h at 70 °C in the presence or absence of 2.5 µM Sso2081, 
the HEPN ribonuclease Csx1 (0.5 µM) together with radioactively labelled Csx1 substrate 
RNA were added. Transcript levels of the sso2081 gene are about 2-fold higher than those of 
the csx1 gene in uninfected S. solfataricus cells 18, and large changes in expression of neither 
gene was observed on infection with the STIV virus 22. Target RNA binding by Csm activates 
the Cyclase domain, switching on cA4 production. The Cyclase domain is deactivated when 
target RNA is cleaved and dissociates from Csm, leaving the complex free to bind to further 
targets. Higher target RNA concentrations thus result in higher levels of cA4 and stronger 
activation of Csx1, which degrades a labelled substrate RNA (Fig. 4a). The presence of 
Sso2081 abrogated the activation of Csx1 in a target RNA concentration-dependent manner. 
This recapitulates the situation likely to prevail in cells infected with a virus, where viral RNA 
load determines the extent of cOA production and speed of subsequent clearance by the Ring 
nuclease (Fig. 4b).   
Thus, we have identified a family of CARF-domain containing Ring nucleases as the enzymes 
responsible for the degradation of cyclic oligoadenylate, which is synthesised by type III 
CRISPR systems in response to detection of viral RNA. The Ring nucleases act as the “off-
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switch” for the system, limiting the damage caused by the HEPN ribonucleases activated by 
cOA once invading RNA has been cleared from the cell. The relatively slow kinetics of cOA 
degradation by Ring nucleases are probably consistent with the requirement to maintain the 
antiviral response for an appropriate period, but we cannot rule out the possibility that other 
factors increase the cOA clearance rate under certain circumstances. Clearly, it will be 
important to follow up these biochemical studies with genetic analyses to elucidate the function 
of Ring nucleases in the antiviral cOA-signalling pathway in vivo.  
Many type III CRISPR systems have multiple associated CARF-domain containing proteins, 
some of which may be specialised for the degradation of cOA. Ring nucleases are hard to 
identify using bioinformatic analysis, as they involve the “grafting” of a minimal ribonuclease 
catalytic site on to an extensive cOA binding site in the CARF domain. In a minimal system, it 
is possible that a single enzyme has a C-terminal HEPN family ribonuclease coupled to an N-
terminal CARF family Ring nuclease. This would allow cOA binding to rapidly switch on the 
ribonuclease activity and then slowly auto-deactivate by cOA cleavage. However, 
specialisation of CARF proteins as Ring nucleases would yield the advantage of allowing 
levels of cOA-activated ribonuclease and cOA-degrading Ring nuclease activity to be 
controlled independently. It is also possible that cA6 rings such as those generated in 
Streptococcus thermophilus will be processed differently, as they are likely to have more 
conformational flexibility than cA4. The recent identification of a wide range of as-yet 
uncharacterised CARF domain proteins across the prokaryotes 8 suggests that we have only 
scratched the surface of this system. These are fruitful areas for future studies. 
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Figure 1. Purification and identification of the enzyme that degrades cA4 
S. solfataricus cell lysate was fractionated by a, phenyl-sepharose, b, size exclusion and c, 
heparin chromatography. At each stage, fractions were assayed for cA4 conversion activity 
using radioactive cA4, and active fractions generating product X (indicated by shaded boxes) 
were pooled for the next stage. d, Following the heparin column, each fraction was assayed 
and analysed by SDS-PAGE. The band corresponding to the peak of activity (arrowed) was 
excised from the gel and identified by mass spectrometry as Sso2081, a CARF domain 
protein. e, Purified recombinant Sso2081 and 1393 degrade cA4, but Csx1 does not. f, Only 
Csx1 degrades linear RNA in the presence of cA4. Panels a-f are representative of at least 
duplicate experiments. 
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Figure 2. Kinetics and products of Ring nuclease activity 
a, Single turnover kinetic analysis of cA4 cleavage by Sso2081 and Sso1393. Sso2081 is a 
ten-fold faster enzyme. Data points are the means of triplicate measurements, with standard 
deviation shown, and are technical replicates representative of duplicate experiments. b, TLC 
analysis of substrates and products. Lane 1 shows cA4 synthesised by the Csm complex. Lane 
2 shows the product (X) of conversion by Sso2081 after 20 min. Lane 3 shows product (X) 
following phosphorylation by PNK. Lanes 4-7 show the products (X and Y) of cA4 conversion 
by Sso1393 after 20 and 120 min, respectively, before and after PNK treatment. Lanes 8 and 
9 are markers for P-A2>P and P-A4>P generated by the MazF nuclease. This gel is 
representative of duplicate experiments. c, d, LC-HRMS analysis of cA4 cleavage by Sso2081 
and Sso1393, respectively, showing ion chromatograms extracted for m/z 657.10 ± 0.5 
corresponding to cA4-2, A4>P-2 and A2>P-1. The control is cA4 incubated for 150 min without 
enzyme. Traces for the conversion of cA4 by Sso2081 after 60 min, and by Sso1393 after 60 
and 150 min are shown. Products X and Y are indicated. The bottom traces show the linear 
oligoadenylates A2>P and A4>P, generated by MazF, as standards. The data are 
representative of at least duplicate experiments. 
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Figure 3. Structure and mechanism of Ring nucleases 
a, Structure of the CARF domain of Sso1393 with cA4 docked. The active site residues K168 
and S11 are shown. b, Kinetic analysis of Sso1393 (wild-type, S11A and K168A variants) and 
Sso2081 (wild-type, S11A and R105A/K106A variants). Catalytic rate constants under single 
turnover conditions are plotted. The data are derived from triplicate rate measurements 
(Figure S6d), with means and standard errors shown. These are technical replicates 
representative of duplicate experiments. c, Cartoon showing the reaction scheme for 
conversion of cyclic to linear A4>P and A2>P. S11 may participate in the correct positioning of 
the 2’-OH group of the ribose to facilitate nucleophilic attack, whilst the basic residue K168 
(and R105/K106 in Sso2081) may stabilise the penta-covalent phosphorus formed in the 
transition state. 
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Figure 4. Reconstitution of the cOA signalling pathway 
a, The Csm effector generates cA4 in proportion to the amount of viral target RNA present 14, 
activating the HEPN nuclease Csx1. The presence of Sso2081 (2.5 µM) for 1 h prior to the 
addition of Csx1 (0.5 µM) for 20 min at 70 °C reversed Csx1 activation partially when 10 nM 
target RNA was present, and fully when lower amounts of RNA were used. Control c shows 
the experiment in the presence of Sso2081 and absence of target RNA. Levels of cA4 and 
A2>P were monitored by TLC. The data are representative of three separate experiments. b, 
Schematic of the cOA signalling system. Type III effectors loaded with crRNA bind to viral 
target RNA, activating the HD nuclease, which targets viral DNA, and the Cyclase domain. 
cOA is synthesised, activating the Csx1 ribonuclease. Target RNA cleavage and subsequent 
dissociation deactivates the Cyclase domain, stopping synthesis of cOA. The Ring nucleases 
complete the deactivation of the antiviral state by degrading extant cOA. 
 
Methods  
 
Purification of cOA degrading enzyme from S. solfataricus cellular extract 
S. solfataricus (Sso) P2 was grown as previously described 23 and cells pelleted by 
centrifugation at 4000 rpm (Beckman Coulter Avanti JXN-26; JLA8.1 rotor) for 15 min at 4 °C. 
Cells were suspended in buffer A containing 100 mM sodium phosphate pH 7.0 and 1.5 M 
ammonium sulphate with one EDTA-free protease inhibitor tablet (Roche). Cells were lysed 
by sonicating six times for 1 min with 1 min rest intervals on ice, and the lysate was 
ultracentrifuged at 40000 rpm (Beckman Coulter Optima L-90K; 70 Ti rotor)  and 4 °C for 45 
min before filtering and loading onto a phenyl-sepharose column (GE Healthcare) pre-
equilibrated with buffer A. Protein was eluted with a linear gradient of buffer B containing 100 
mM sodium phosphate pH 7.0 across 10 column volumes (CV). Each fraction was assayed 
for cyclic tetra-adenosine (cA4) degradation activity and fractions displaying cA4 degradation 
were pooled and concentrated using a 10,000 molecular weight cut-off ultracentrifugal 
concentrator (Amicon Millipore). Concentrated protein was then further separated by size-
exclusion chromatography (S200; 26/60 GE Healthcare) in buffer containing 20 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) pH 7.5 and 150 mM KCl. Fractions 
were assayed for cA4 degradation, and active fractions pooled and concentrated as previously, 
exchanging into 10 mM 2-(N-morpholino)ethanesulfonic acid (MES) pH 6.0 buffer during 
concentration. Concentrated protein was then loaded on to a 5 ml HiTrap heparin column (GE 
Healthcare) equilibrated with 10 mM MES pH 6.0 buffer, washing unbound protein with 8 % 
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buffer C containing 10 mM MES pH 6.0 and 1.0 M NaCl for 2 CV. Protein was eluted by a 
linear gradient to 30 % buffer C across 5 CV followed by a gradient to 100 % buffer C across 
4 CV. After assaying for cA4 degradation, fractions of interest were visualised by sodium-
dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE). A protein band of ~18 kDa, 
the presence and abundance of which corresponded to a peak in cA4 degradation was 
excised, trypsin digested and identified by mass spectrometry.  
 
Cloning, expression and purification of Sso2081, Sso1393 and variants 
The cloning, expression and purification of Sso1389 (Csx1) has been described previously 14. 
A synthetic gene encoding Sso2081 was purchased from Integrated DNA Technologies, 
Coralville, IA, United States (IDT), while Sso1393 was PCR amplified from S. solfataricus P2 
genomic DNA. Genes encoding Sso2081 and Sso1393 were  cloned into the pEHisTEV vector 
24, and transformed into E. coli DH5a competent cells. Sso2081 S11A, Sso2081 
R105A/K106A, Sso1393 S11A and Sso1393 K168A variants were generated by site directed 
mutagenesis using the QuickChange Site-Directed Mutagenesis protocol (Agilent 
Technologies), with DNA primers purchased from IDT. Sequence verified constructs were 
transformed into C43 (DE3) E. coli cells for protein expression.   
Expression of recombinant Sso2081 and variants was induced with 0.4 mM isopropyl b-D-1-
thiogalactopyranoside at an OD600 of ~0.8, and cells incubated at 16 °C overnight with shaking 
at 180 rpm before harvesting by centrifugation at 4000 rpm (JLA8.1 rotor) at 4 °C for 15 
minutes. Cells were suspended in lysis buffer (50 mM Tris-HCl pH 8.0, 0.5 M NaCl, 10 mM 
imidazole and 10% glycerol) with 1 mg/ml chicken egg lysozyme (Sigma-Aldrich) and one 
EDTA-free protease inhibitor tablet. Cells were sonicated six times for 1 min with 1 min rest 
intervals on ice at 4 °C. Cell lysate was then ultracentrifuged at 40000 rpm (70 Ti rotor) for 45 
min at 4 °C, filtered and loaded onto a 5 ml HisTrap FF column (GE Healthcare) equilibrated 
with buffer D containing 50 mM Tris-HCl pH 8.0, 0.5 M NaCl, 30 mM imidazole and 10% 
glycerol. After washing unbound protein with 20 CV buffer D, recombinant Sso2081 and 
mutants were eluted with a linear gradient (0-20%) of buffer D supplemented with 0.5 M 
imidazole across 15 CV, then holding at 20% for 4 CV. Pooled fractions were concentrated as 
described previously, and the hexa-histidine affinity tag was removed by incubating protein 
with Tobacco etch virus (TEV) protease (10:1) for 4 h at 37 °C. His-tag cleaved Sso2081 was 
isolated from TEV by affinity chromatography as detailed above, eluting with buffer D prior to 
further purification by size-exclusion chromatography (S200 26/60; GE Healthcare) in buffer 
containing 20 mM Tris-HCl pH 8.0, 0.5 M NaCl and 1 mM DTT.  
Expression of recombinant Sso1393 (wild-type and variants) was induced as above, except 
cells were grown at 16 °C overnight before harvest.  Cells were lysed and protein purified as 
for Sso2081. All proteins were aliquoted, flash frozen with liquid nitrogen, and stored at -80 
°C.  
 
Cyclic oligoadenosine nuclease assays and kinetic analysis 
32P-a-ATP incorporated cyclic oligoadenylate was generated using the Csm complex as 
previously described 14. Briefly, the Csm complex was incubated for 2 h at 70 ºC in 100 µl 
final reaction volume in a pH 5.5 buffer containing 20 mM MES, 100 mM potassium 
glutamate and 1 mM DTT supplemented with 2 mM MgCl2, 1 mM ATP, 3 nM 32P-a-ATP and 
100 nM A26 target RNA: 
 (5’-AGGGUCGUUGUUAAGAACGACGUUGUUAGAAGUUGGGUAUGGUGGAGA). The 
reaction was stopped by phenol-chloroform extraction followed by chloroform extraction. 
Sso1393, Sso2081, and their mutants were assayed for labelled cA4 degradation by incubating 
2 µM protein dimer with 1/300 diluted Csm generated 32P labelled cOA (0.33 µl per 100 µl 
reaction) in buffer E (20 mM 2-amino-2-(hydroxymethyl)-1,3-propanediol pH 8.0, 100 mM 
NaCl, 1 mM EDTA and 1 mM DTT) at 70 °C. At desired time points, a 10 µl aliquot was 
removed, and the reaction quenched by adding to chilled phenol-chloroform (Ambion). 
Subsequently, 5 µl of deproteinised reaction product was extracted into 5 µl 100% formamide 
for denaturing PAGE. Control reactions include cOA incubated in buffer E without protein at 4 
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°C and at 60 °C up to the endpoint of each experiment (typically 20, 120 or 180 min) phenol-
chloroform extracted as above. All experiments were carried out in triplicate.  cA4 degradation 
was visualised by phosphorimaging following denaturing PAGE (7M Urea, 20% acrylamide, 
1x TBE). For kinetic analysis, cA4 cleavage was quantified using the Bio-Formats plugin 25 of 
ImageJ 26 as distributed in the Fiji package 27 and fitted to a single exponential curve using 
Kaleidagraph (Synergy Software), as described previously 28.  
 
HEPN nuclease deactivation assays 
For degradation of cA4, Csm generated cOA was incubated with 2 µM Sso2081 dimer or 4 µM 
Sso1393 dimer in buffer E for 60 min and 120 min, respectively.  Subsequently, the reaction 
was deproteinised by phenol-chloroform extraction and diluted two-fold in RNase free water. 
As a control reaction, cOA was mock treated in buffer with water in place of protein and 
deproteinised as before. 500 nM Csx1 dimer was incubated with 50 nM A1 RNA and either no 
cOA activator, 1/100 diluted untreated Csm cOA, 1/100 mock treated cOA or 1/100 Ring 
nuclease treated cOA in buffer containing 20 mM MES pH 5.5, 100 mM K-glutamate and 1 
mM DTT for 60 min at 70 °C. Reactions were quenched by the addition of a reaction volume 
equivalent of 100% formamide, and RNA cleavage was assessed by phosphorimaging 
following denaturing PAGE.  
 
Reconstitution of the cOA signalling pathway 
The Csm complex (70 nM carrying the crRNA targeting A26) was incubated for 1 h at 70 ºC 
in presence of 2.5 µM of Sso2081 dimer and various concentrations of target A26 ssRNA in a 
reaction containing 20 mM MES pH 6.0, 100 mM NaCl, 1 mg/ml BSA, 2 mM MgCl2, 0.5 mM 
ATP and a 5’-labeled A1 ssRNA that is not recognised by the Csm complex (5’-
AGGGUAUUAUUUGUUUGUUUCUUCUAAACUAUAAGCUAGUUCUGGAGA). After 1 h 
incubation, 500 nM of Csx1 dimer was added to the reaction for a further 20 min. Reactions 
were quenched by deproteination with phenol-chloroform extraction and run on a 20% 
acrylamide 7 M urea denaturing gel prior to phosphorimaging to visualise A1 RNA cleavage. 
  
Generation of standards using the MazF nuclease 
The E. coli toxin-antitoxin MazEF was purified as previously described 14. Active MazF was 
liberated by either trypsin (Promega) digestion (1600:1) at 37 °C for 15 min or by incubation 
with Factor X Activated (0.1 unit per 1 mg of protein; Sigma-Aldrich) in FXa buffer containing 
10 mM Tris-HCl pH 8.0 and 1 mM DTT. For generating linear oligoadenylates A2>P (5’ 
hydroxyl-Ap-Ap with a 2’,3’-cyclic phosphate) and A4>P, 30 µM A2 (AAACAUCAG) or A4 
(AAAAACAUCAG) RNA was incubated with MazF in FXa buffer for 1 h at 37 °C. RNA was 
deproteinised by phenol-chloroform extraction followed by chloroform extraction. For use as 
standards, A2>P and A4>P linear oligoadenylates were 5’-end labelled using 32P-g-ATP and 
T4 Polynucleotide Kinase (PNK; Thermo Fisher Scientific) via its forward reaction.  
 
Thin-layer chromatography  
Experiments were performed using silica gel on a 20 x 20 cm TLC plate (Supelco Sigma-
Aldrich) containing a fluorescent indicator, allowing visualisation of non-radioactive products 
by UV shadowing. Prior to loading, all samples were deproteinised by phenol-chloroform 
followed by chloroform extraction. Non-radioactive or radioactive samples (from 0.1 µl to 2 µl) 
were loaded 1 cm above the bottom of the TLC plate. The TLC plate was then placed in a 
sealed glass chamber pre-warmed at 30 °C and containing 0.5 cm of a running buffer 
composed of H2O (30 %), ethanol (70 %) and ammonium bicarbonate (0.2 M), pH 9.3. The 
buffer was allowed to rise along the plate through capillary action until the migration front 
reached 15 cm. The plate was dried and radioactive sample migration visualised by 
phosphorimaging while non-radioactive sample migration was pictured under UV light (254 
nm).  
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Liquid chromatography-high resolution mass spectrometry (LC-HRMS) 
LC-HRMS analysis was performed on a Thermo Scientific Velos Pro instrument equipped with 
HESI source and Dionex UltiMate 3000 chromatography system. Samples were deproteinised 
as described for TLC. Compounds were separated on a Kinetex 2.6 µm EVO C18 column (2.1 
´ 100 mm, Phenomenex) using a linear gradient of acetonitrile (B) against 20 mM ammonium 
bicarbonate (A): 0 – 5 min 2 % B, 5 – 33 min 2 – 15 % B, 33 – 35 min 15 – 98 % B, 35 – 
40 min 98 % B, 40 – 41 min 98 – 2 % B, 41 – 45 min 2 % B. The flow rate was 350 µl min-1 
and column temperature was 40 °C. UV data were recorded at 254 nm. Mass data were 
acquired on the FT mass analyzer in negative ion mode with scan range m/z 150 – 1500 at a 
resolution of 30,000. Source voltage was set to 3.5 kV, capillary temperature was 350 °C, and 
source heater temperature was 250 °C. Data were analysed using Xcalibur (Thermo 
Scientific). Extracted ion chromatograms were smoothed using the Boxcar function at default 
settings. 
 
Data availability 
All electrophoretic separation and kinetic data are included as source data and supplementary 
information. Raw MS data are available on request from M.F.W. 
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Extended Data Figures 
 
Extended data figure 1. Genome organisation of the CRISPR-Cas locus of S. 
solfataricus 
The type I-A, III-B and III-D effector complex operons are depicted, along with genes encoding 
adaptation proteins and the position of the six CRISPR loci (A-F). Genes outlined in blue 
encode proteins with CARF domains. The structures of three CARF family proteins are shown 
with CARF domains coloured green, along with the structure of cA4. 
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Extended data figure 2. Structure-guided sequence alignment of Sso1393, Sso2081 
and orthologues.  
Multiple sequence alignment showing Sso1393 with three homologues from the Sulfolobales 
aligned with Sso2081 and three homologues. Secondary structure is shown above the 
alignment, based on the structure of Sso1393 (PDB 3QYF). Ser-11 and Lys-168 are indicated 
by asterisks. Conserved residues are shaded. Sequences aligned are from S. solfataricus 
(Sso1393, Sso2081); S. islandicus REY15A (SiRE_0811, SiRE_0455); S. islandicus M.16.4 
(M164_0884); S. acidocaldarius (Saci_1063) and S. tokodaii (Stk_17430). 
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Extended data figure 3. Single-turnover kinetic analysis of cA4 degradation by a, 
Sso2081 and b, Sso1393. 
Representative phosphorimages of denaturing polyacrylamide gel electrophoresis (PAGE) 
analysing the reaction of radioactively labelled cA4 with a, 2 µM Sso2081 or b, Sso1393 at 60 
°C over time. Triplicate experiments were carried out, quantified by phosphorimaging and the 
fraction of cA4 cleaved plotted in Figure 3b. 
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Extended data figure 4. Sso2081 and Sso1393 cA4 degradation mechanism 
investigated by TLC. 
Csm generated cOA (lane 1) was incubated with 2 µM Sso2081 dimer at 60 °C to determine 
the intermediate (Y) and final (X) reaction product over time (lanes 2-10). Lanes 11-13 show 
reaction product seen in lanes 2, 4 and 6, 5’-end phosphorylated using T4 polynucleotide 
kinase (PNK) for identification of reaction intermediates and products by comparison to 5’-end 
phosphorylated MazF nuclease generated HO-A2>P and HO-A4>P standards. Lanes 14 & 15 
show the reaction products of 2 µM Sso1393 dimer incubated with cOA at 70 °C for 20 and 
120 min, respectively. Reaction product from lanes 14 & 15 are 5’-end phosphorylated by PNK 
for comparison to P-A2>P and P-A4>P standards. Comparison of PNK treated reaction product 
to standards showed the presence of a low amount of intermediate (P-Y) during the Sso2081 
cA4 cleavage reaction, which migrated similarly to the P-A4>P standard and did not change in 
abundance over time, whereas the abundance of the final product (P-X) increased over time. 
In contrast, comparison of Sso1393 PNK treated 20 min and 120 min reaction products 
showed a decrease of the intermediate (P-Y) over time and increase of product (P-X).  
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Extended data figure 5. LC-MS analysis of Sso2081 reactions. 
a, Ion chromatograms extracted for m/z 657.1 (cA2-1, A2>P-1, cA4-2, A4>P-2). Individual lanes 
are labelled. cOAs (mainly cA4), derived from reaction of Csm with ATP, was incubated with 
Sso2081 for 60 and 150 min. Linear oligoadenylates with 2’,3’-cyclic phosphate were derived 
from hydrolysis of A4 RNA oligonucleotide with MazF. 
b, UV traces at 254 nm. Peaks that change in intensity over the course of the enzymatic 
reaction are indicated by arrows. The three peaks that decreased or increased over the 
course of the reaction all match the changes in abundance of the m/z 657.1 species. No 
changes are observed after 60 min reaction time. The broad peak at 4.9 min is an unknown 
contaminant likely resulting from the phenol-chloroform extraction. Shifts in retention time 
are possibly due to matrix effects. 
c, Mass spectra for cA4 and product X. Calculated for C20H23N10O12P2-1 (cA2 / A2>P) m/z 
657.0978, found 657.0966 (dm -1.8 ppm); calculated for C40H46N20O24P4-2 (cA4 / A4>P) m/z 
657.0978, found 657.0967 (dm -1.6 ppm). The data presented are representative of duplicate 
experiments. 
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Extended data figure 6. LC-MS analysis of Sso1393 reactions. 
a, Ion chromatograms extracted for m/z 657.1 (cA2-1, A2>P-1, cA4-2, A4>P-2). Individual lanes 
are labeled. cOAs (mainly cA4), derived from reaction of Csm with ATP, was incubated with 
Sso1393 for 60 and 150 min or without Ring nuclease for 150 min. A control in which the 
ATP from the Csm cyclase reaction had been omitted was also analysed as control. Linear 
oligoadenylates with 2’,3’-cyclic phosphate were derived from hydrolysis of suitable DNA 
oligonucleotide subtrates with the toxin MazF; whereas cA2 was a commercially available 
standard. The traces show clearly the difference in retention time between the linear and 
cyclic isomers. 
b, UV traces at 254 nm. Peaks that change in intensity over the course of the enzymatic 
reaction are indicated by arrows. The three peaks that decreased or increased over the 
course of the reaction all match the changes in abundance of the m/z 657.1 species. The 
broad peak at 4.1 – 6 min is an unknown contaminant likely resulting from the phenol-
chloroform extraction.  
c, Mass spectra for species X and Y. Calculated for C20H23N10O12P2-1 (cA2 / A2>P) m/z 
657.0978, found 657.0968 (dm -1.4 ppm); calculated for C40H46N20O24P4-2 (cA4 / A4>P) m/z 
657.0978, found 657.0967 (dm -1.6 ppm). The data presented are representative of duplicate 
experiments. 
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Extended data figure 7. Specificity of Sso2081 for cyclic nucleotide substrates. 
Various cyclic di- and oligonucleotides were incubated in the absence (ctrl) or presence of 
Sso2081 as described in Materials and Methods. Dinucleotides and cA6 were obtained from 
BIOLOG Life Science Institute (Bremen), cA4 was obtained from an enzymatic reaction with 
S. solfataricus Csm. Protein-free extracts were analyzed by LC-HRMS essentially as before 
but using a shorter column and gradient.  EICs for substrate and expected products are 
shown in each panel. No reaction was observed for any of the cyclic dinucleotides. cA4, was 
completely converted to linear A2>P by Sso2081 whilst only a small percentage of cA6 was 
converted, demonstrating a clear preference of Sso2081 for its physiological substrate cA4. 
The data presented are representative of duplicate experiments. 
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Extended data figure 8. Structure and kinetic analysis of Sso1393 and Sso2081. 
a, Structure of Sso1393 (PDB 3QYF), with cA4 docked at the active site. This is an orthogonal 
view to that shown in Figure 3. The CARF domain is coloured green. The side chains of Ser-
11 and Lys-168 are shown. 
b, Model of the Sso2081 structure. Only the CARF domain (aa1-125) is modelled. Conserved 
residues Ser-11, Arg-105 and Lys-106 are labelled. Model generated using Phyre 29. 
c, Representative phosphorimages of denaturing PAGE assessing the cA4 degradation activity 
of Sso2081 compared to its catalytically inactive R105A/K106A mutant over time (left hand 
panel), and Sso1393 activity compared to its K168A mutant (right hand panel). All reactions 
were carried out at 70 °C with 2 µM protein dimer. The data presented are representative of 
triplicate experiments. 
d, Single-turnover kinetics of Sso2081 and Sso1393 plotted alongside their S11A active site 
mutants and fitted to an exponential equation. Rate constants (fraction of cA4 cleaved per min) 
are displayed with the legend (Sso2081; 0.23 ± 0.01 min-1, Sso2081 S11A; 0.066 ± 0.002 min-
1, Sso1393; 0.024 ± 0.0003 min-1, Sso1393 S11A; 0.00076 ± 0.001 min-1). Experiments were 
carried out in triplicate with means and standard deviation shown. The data presented are 
technical replicates and are representative of duplicate experiments. 
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Extended data figure 9. Ring nucleases abrogate activation of the Csx1 nuclease by 
converting cA4 to A2>P. 
a, In the absence of cA4, Csx1 had no ribonuclease activity (lane c), but addition of cA4 resulted 
in degradation of the substrate RNA molecule. When cA4 was pre-incubated for 1 h at 70 °C 
with Sso2081 in buffer E before addition to the assay, Csx1 ribonuclease activity was 
abolished. Mock treatment using buffer instead of Sso2081 (denoted ‘*’) had no effect. 
b, As for a, but pre-incubated with Sso1393 for 2 h at 70 °C. 
c, Using radioactive cA4, the deactivation of Csx1 by Sso2081 and Sso1393 was observed to 
correlate with the conversion of cA4 into A2>P. Results shown are representative of at least 
triplicate experiments. 
 
 
 
